["The image was published here on Twitter on December 11, 2020. It has been shared more than 300 times.", "The simplified Chinese-language tweet translates to English in part\u00a0as: \u201cCOVID-19: Four Pfizer vaccine volunteers suffered from Bell's palsy.", "\u201cIsn't the so-called big technology killing people?\u201d", "The Pfizer-BioNTech Covid-19 vaccine\u00a0has been\u00a0approved for use by a handful of countries around the world, including Britain and the United States, as\u00a0reported\u00a0by AFP.", "Identical images, alongside a similar claim, were also shared tens of thousands of times on Twitter here, here and here, and Facebook here and here, including these posts here and here in Africa.", "The\u00a0claim, however, is misleading.", "A reverse image search on Yandex of the image in the misleading tweet found the same image in this\u00a0video published on YouTube channel of Indonesian news outlet TribunnewsWIKI, on January 23, 2020.", "The video\u2019s Indonesian headline translates to English as: \u201cBell's Palsy - A condition where facial muscles are weakened or paralyzed\u201d.", "The description reads, in part: \u201cMost people think Bell's Palsy is a stroke because of the similarity in the symptoms, namely paralysis. However, it\u2019s not the reality, the two diseases are different. Bell's palsy is limited to the facial muscles and most sufferers recover completely within six months... This disease occurs when the nerves that control the facial muscles are inflamed, swollen, or compressed. Bell's palsy is caused by trauma to the seventh cranial nerve.\u201d", "The image in the misleading tweet matches the YouTube video from its three-second mark to its 51-second mark.", "Below is a screenshot comparison of the image in the misleading tweet (L) and TribunnewsWIKI\u2019s YouTube video at its three (C) and 51-second mark (R) :", "The image was also shared here in an article about Bell's palsy on BMJ Best Practice, a UK based healthcare site. The article was last updated on November 20, 2019, according to the dateline.", "Pfizer and BioNTech SE announced the start of their clinical trials in Germany on April 29,\u00a02020.", "The statement reads, in part: \u201cBioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) and Pfizer Inc. (NYSE: PFE) have announced that the first cohort of BioNTech\u2019s Phase 1/2 clinical trial has been dosed. Twelve study participants were dosed with vaccine candidate BNT162 in Germany since dosing began on April 23, 2020. The trial is the first clinical trial of a COVID-19 vaccine candidate in Germany. Pfizer and BioNTech plan to initiate trials for BNT162 in the United States upon regulatory approval, which is expected shortly.\u201d", "According to this December 10, 2020 FDA report, there were \u201cfour cases of Bell\u2019s palsy in the vaccine group compared with no cases in the placebo group\u201d, but not as a direct result of receiving the vaccine.", "The report\u00a0states, in part: \"Among non-serious unsolicited adverse events, there was a numerical imbalance of four cases of Bell\u2019s palsy in the vaccine group compared with no cases in the placebo group, though the four cases in the vaccine group do not represent a frequency above that expected in the general population.\"", "It goes on to state: \u201cThe observed frequency of reported Bell\u2019s palsy in the vaccine group is consistent with the expected background rate in the general population, and there is no clear basis upon which to conclude a causal relationship at this time, but FDA will recommend surveillance for cases of Bell\u2019s palsy with deployment of the vaccine into larger populations.\"", "Follow us", "Copyright \u00a9 AFP 2017-2023. All rights reserved. Users can access and consult this website and use the share features available for personal, private, and non-commercial purposes.  Any other use, in particular any reproduction, communication to the public or distribution of the content of this website, in whole or in part, for any other purpose and/or by any other means, without a specific licence agreement signed with AFP, is strictly prohibited.  The subject matter depicted or included via links within the Fact Checking content is provided to the extent necessary for correct understanding of the verification of the information concerned.  AFP has not obtained any rights from the authors or copyright owners of this third party content and shall incur no liability in this regard.  AFP and its logo are registered trademarks."]